That was funny!

I would be shocked at a 2014 buyout - but there have been a few instances of such early phase buyouts in the past. Given the large number of biotechs though - that number is absolutely tiny. I would not be shocked to see such action in 2015. We will know so much more by then and may be moving quickly with one of the rapid path designations.